The global in vitro toxicology testing market is expected to USD 27.36 Billion by 2021 from USD 14.15 Billion in 2016, at a CAGR of 14.1% between 2016 and 2021. The major drivers for the market include opposition to animal testing, new & promising technologies, increasing R&D to detect toxicity at early stages and insufficient databases to facilitate the use of in vitro test methods are driving the growth of the global market. The growing demand for in vitro toxicology testing in the European market will provide new growth opportunities for this market.
The report provides a granular understanding of the in vitro toxicology testing market. This report segments the global market on the basis of product, type, toxicity endpoints & tests, technology, method, industry and geography. The product segments included in this report are assays, reagents & labware, and services. The assays segment accounts for the largest share of the global market in 2016.
Complete report on in vitro toxicology testing market spread across 255 pages, with 107 tables and 135 figures is now available at http://www.rnrmarketresearch.com/in-vitro-toxicology-testing-market-by-product-type-adme-toxicity-endpoints-tests-carcinogenicity-dermal-toxicity-genotoxicity-technology-genomics-transcriptomics-method-cellular-assays-industry-ph-st-to-2021-market-report.html
The toxicity endpoints & tests segment includes systemic toxicity, dermal toxicity, carcinogenicity, ocular toxicity, skin sensitization & Irritation, genotoxicity, neurotoxicity, and organ toxicity. The technology segment is segmented into omics technologies, cell culture technology, high-throughput technologies, and molecular imaging technologies.
The method segments included in this report in silico methods, biochemical assays, cellular assays, and ex vivo models. The industry segment includes cosmetics & household products, pharmaceutical industry, diagnostics, chemical industry, and food industry.
The geographic segments included in this report are Europe, North America, Asia, and the Rest of the World (RoW). The report maps each product, type, toxicity endpoints & tests, technology, method, industry segment in 6 geographic and regional segments. Geographic analysis reveals that Europe accounted for the largest share of the global in vitro toxicology testing market in 2016. Growth in this market can be attributed to rapidly increasing aging population and the subsequent rise in chronic diseases, costly technological advances. Similarly Asia is estimated to be the fastest growing market of the global market in 2015. The wide applications of in vitro toxicology testing products in testing of different endpoints done by various industries such as cosmetics, pharmaceutical industry are the major driving factor for market in this region.
The major players in this market include Agilent Technologies, Inc. (U.S.), Covance, Inc. (A subsidiary of LabCorp) (U.S.), Bio-Rad Laboratories, Inc. (U.S.), General Electric Company (U.S.), Eurofins Scientific SE (Luxembourg), BioReliance, Inc. (A subsidiary of Merck & Co, Inc.) (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.), and Cyprotex (U.K.).
Get a Sample Copyof This Report now at http://www.rnrmarketresearch.com/contacts/request-sample?rname=607628
Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and to help them make important strategic growth decisions.
The report provides insights on the following:
Product Development/Innovation: Product portfolios of the top players in the in vitro toxicology testing market. Detailed insights on upcoming technologies, research and development activities, and new product launches in the insights on upcoming technologies market
Competitive Assessment: In-depth assessment of market shares, strategies, geographic and business segments, and product portfolios of the leading players in the in vitro toxicology testing market
Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various in vitro toxicology testing across geographies
Market Diversification: Exhaustive information about new products, recent developments, and investments in the in vitro toxicology testing market
In Vitro Diagnostics (IVD) Quality Controls Market by Application (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Microbiology) Source (Serum, Blood, Plasma Based Controls) Type (Instrument Specific & Third Party Controls) - Forecast to 2020. Is now available at Rnrmarketresearch.com at http://www.rnrmarketresearch.com/in-vitro-diagnostics-ivd-quality-controls-market-by-application-immunoassay-clinical-chemistry-molecular-diagnostics-microbiology-source-serum-blood-plasma-based-controls-type-instrument-specific-third-st-to-2020-market-report.html the report says that The global In Vitro Diagnostics Quality Controls products market is expected to reach USD 979.0 Million by 2020, at a CAGR of 3.6% from 2015 to 2020. Growth in this market is mainly driven by factors such as the increasing number of accredited clinical laboratories and growing adoption of third-party quality controls to ensure unbiased test results. Moreover, the increasing use of multi-analyte controls and rising focus of key players on emerging countries are expected to offer new growth opportunities for players operating in this market. However, uncertainty in reimbursement and lack of regulations are restraining the growth of this market.